Panbela Therapeutics
Minnesota City
About Panbela Therapeutics
Panbela Therapeutics is a next-generation biopharmaceutical company developing disruptive therapeutics for serious unmet medical needs. The company’s initial programs are aimed at diseases of the pancreas, including pancreatic cancer and pancreatitis. Panbela Therapeutics has scientific collaborations with pancreatic disease experts at Honor Health in Scottsdale, Arizona, Cedars Sinai Medical Center in Los Angeles, the University of Minnesota, Mayo Clinic Scottsdale, the Austin Health Cancer Trials Centre, and the Ashford Cancer Centre in Adelaide, Australia. Founded in 2011, the company is based in Minnesota, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $64.4M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jan 2024)
- Ticker: nasdaq:PBLA
- Website: panbela.com
- Phone: (952)479-1196
Industries & Categories
Biotechnology, Health Care, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/panbela-therapeutics-196499 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.